Sign in

CIK 0001069530

  • Non-accelerated filer
  • Smaller reporting company

FILANA THERAPEUTICS, INC.

Sign in to watch
Ticker
FLNA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911911336
Phone
+1 512-501-2444
Business address
6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
Former names
CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
  1. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.01 ($80,100)
  2. 4 Open-market buy 10% owner bought 5,200 shares at $7.93 ($41,236)
  3. 4 Open-market buy 10% owner bought 134,000 shares at $8.03 ($1,076,020)
  4. 4 Open-market sale President and CEO sold 35,000 shares at $8.28 ($289,800)
  5. 4 Open-market buy Chief Operating & Med. Officer bought 1,321 shares at $4.43 ($5,852)
  6. 4 Open-market buy Chief Financial Officer bought 4,602 shares at $4.43 ($20,387)
  7. 4 Open-market sale Operating & Med. Officer sold 4,000 shares at $8.32 ($33,280)
  8. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.41 ($84,100)
  9. 4 Open-market sale President and CEO sold 35,000 shares at $8.56 ($299,600)
  10. 4 Open-market sale Chief Operating & Med. Officer sold 4,000 shares at $8.54 ($34,160)
  11. 4 Open-market buy 10% owner bought 2,900 shares at $7.88 ($22,852)
  12. 4 Open-market buy 10% owner bought 700 shares at $7.88 ($5,516)
  13. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $7.86 ($78,600)
  14. 4 Open-market buy 10% owner bought 4,064 shares at $7.88 ($32,024)
  15. 4 Open-market sale President and CEO sold 35,000 shares at $8.39 ($293,650)
  16. 4 Open-market sale Chief Operating & Med. Officer sold 4,000 shares at $8.37 ($33,480)
  17. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.83 ($88,300)
  18. 4 Open-market sale President & CEO sold 35,000 shares at $8.56 ($299,660)
  19. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $8.33 ($83,300)
  20. 4 Open-market sale President and CEO sold 35,000 shares at $8.38 ($293,234)

Page 25 of 30 · 591 filings